Keros Therapeutics, Inc. (NASDAQ: KROS)

$11.44 +0.13 (+1.15%)
As of Apr 22, 2026 03:59 PM
Sector: Healthcare Industry: Biotechnology CIK: 0001664710
Market Cap 420.97 Mn
P/E 4.83
P/S 1.72
Div. Yield 0.00
ROIC (Qtr) 0.13
Revenue Growth (1y) (Qtr) 213.58
Add ratio to table...

About

Segments Breakdown of Revenue (2025)

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 VRTX Vertex Pharmaceuticals Inc / Ma 111.64 Bn 28.22 9.30 -
2 REGN Regeneron Pharmaceuticals, Inc. 78.17 Bn 17.32 5.45 1.99 Bn
3 ALNY Alnylam Pharmaceuticals, Inc. 40.41 Bn 146.87 12.83 -
4 RVMD Revolution Medicines, Inc. 28.31 Bn -25.07 34,108.71 -
5 ZLAB Zai Lab Ltd 26.77 Bn -152.75 110.41 0.20 Bn
6 MESO Mesoblast Ltd 24.41 Bn -191.25 1,419.53 0.12 Bn
7 RPRX Royalty Pharma plc 21.27 Bn 27.64 8.94 8.95 Bn
8 MRNA Moderna, Inc. 21.10 Bn -7.46 10.85 0.59 Bn